OpenAlex
PricingAboutJobs
Log inGet started
Work

Nintedanib in the treatment of idiopathic pulmonary fibrosis

HTML

Year: 2015
Type: review
Source: Therapeutic Advances in Respiratory Disease
DOI: 10.1177/1753465815579365
Authors: Mariano E. Mazzei, Luca Richeldi, Harold R. Collard
Institutions: Universidad de Buenos Aires, National Institute for Health and Care Research, NIHR Southampton Respiratory Biomedical Research Unit, University of Southampton, University of California, San Francisco
Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: nintedanib, idiopathic pulmonary fibrosis, tyrosine kinase inhibitors, disease progression, forced vital capacity decline, fibroblast proliferation and migration, extracellular matrix secretion, INPULSIS trials, drug safety and efficacy
SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, FibroGen, Shionogi, National Institutes of Health, Genentech, National Heart, Lung, and Blood Institute
OpenAlex ID: W2119639538
FWCI: 1.803
Cites: 27
Cited by: 87
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security